PFKFB3 and hepatocellular carcinoma: PFKFB3 is a rate-limiting enzyme that has a strong kinase activity promoting the formation of F2,6BP and is usually upregulated in a wide variety of tumors, including hepatocellular carcinoma, where F2,6BP acts as an allosteric modulator promoting the activation of the glycolytic flux [44–46].